AI Summary Afinitor (everolimus) is an oral mTOR inhibitor used in oncology to slow cancer cell growth, typically taken as a 10 mg daily tablet.
Medically reviewed.
Afinitor (everolimus) is an oral prescription medication used in oncology to treat certain cancers. It belongs to the mTOR inhibitor class and works by slowing cancer cell growth and reducing tumor proliferation. It is prescribed under the guidance of a specialist oncology team. Treatment decisions should always be individualized and guided by a healthcare professional.
This page covers Afinitor's role in cancer treatment — how it works, who may be prescribed it, how it is used, benefits, side effects, and monitoring. You can also connect with a liver specialist near you for personalized guidance on whether Afinitor fits your care plan.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ABOUT AFINITOR TREATMENT
Afinitor is a prescription medicine that contains everolimus. It is used in oncology to treat certain cancers. Afinitor belongs to a class of medicines called mTOR inhibitors, the same class as Rapamune (sirolimus).
Afinitor works by slowing cancer cell growth and reducing tumor proliferation, which means the growth and multiplication of tumor cells. It is a targeted therapy that acts on the mTOR signaling pathway.
Everolimus is also sold as Zortress, which is used to prevent organ rejection after liver transplantation. Afinitor is the version used for cancer treatment. It is taken as a daily tablet and is monitored by your oncology team with regular lab work and imaging.
WHO AFINITOR MAY BE SUITABLE FOR
Afinitor is prescribed for certain types of advanced or metastatic cancer. Metastatic means the cancer has spread to other parts of the body. It is usually part of a treatment plan led by a specialist oncology team.
Your healthcare provider may prescribe Afinitor if you need targeted therapy to control tumor growth, if your oncology team recommends mTOR-targeted treatment, or if you need systemic therapy for cancer progression. Systemic therapy means a medicine that works throughout the body.
Because every patient's health profile is different, there is no one-size-fits-all answer to who should take Afinitor. Treatment decisions are individualized and should be made by your oncology team after a full assessment of your cancer, overall health, and treatment goals.
PRESCRIBING OVERVIEW
Afinitor may be considered for people in the following situations:
Afinitor is used under specialist supervision. Your care team will:
HOW AFINITOR CAN HELP CONTROL TUMOR GROWTH
Afinitor blocks the mTOR pathway, a signaling pathway that cells use to grow and divide. By inhibiting this pathway, Afinitor slows the growth and multiplication of cancer cells.
It also reduces tumor angiogenesis and growth signaling. Angiogenesis is the process tumors use to form new blood vessels so they can keep growing.
For people with certain cancers, these actions help control disease progression and support treatment outcomes. Afinitor is not used on its own without oversight. Your oncology team monitors your response with blood counts, liver and kidney function tests, lipid levels, and imaging.
TREATMENT BENEFITS
Cells use the mTOR pathway to grow and divide. Afinitor inhibits this pathway, which slows the proliferation of cancer cells. In practice, this means the medicine works at the cell level to reduce how quickly the cancer multiplies.
Tumors depend on signals that tell them to keep growing. Afinitor reduces tumor angiogenesis, the process tumors use to form new blood vessels, and it lowers growth signaling. This limits the support a tumor receives as it tries to expand.
When cell growth and tumor signaling slow down, the cancer may advance more slowly. This is why Afinitor is used as systemic therapy, meaning it works throughout the body. Your oncology team tracks this effect with imaging and lab tests.
Afinitor supports cancer treatment outcomes in specific malignancies, which are cancers chosen by your oncology team. Results vary from person to person, so your team will decide if this mTOR-targeted approach fits your diagnosis and treatment goals.
Afinitor is a targeted mTOR inhibitor that slows cancer cell growth, reduces tumor growth signaling, and helps control disease progression. It should only be started and monitored under the guidance of a qualified oncology team.
TREATMENT PROCESS
Afinitor is available as oral tablets. Take it exactly as prescribed by your healthcare provider, and check with your pharmacist if you have questions about your tablets.
The typical dose is 10 mg once daily. Your healthcare provider may adjust it based on your indication, how well you tolerate it, and your clinical response.
Take Afinitor at the same time each day, with or without food. Avoid grapefruit products unless your healthcare provider approves them.
Afinitor is generally taken long term, as long as the cancer stays controlled and side effects are manageable. Treatment may continue for months or years, depending on disease progression and response. Do not stop taking it without talking to your healthcare provider.
Store Afinitor at room temperature, away from moisture and heat.
Regular monitoring of blood counts, liver function, kidney function, lipid levels, and treatment response is required. Report any side effects or unusual symptoms to your healthcare provider.
BENEFITS AND SAFETY
Afinitor (everolimus) may help people with certain advanced cancers by slowing cancer cell growth and controlling tumor progression. As a targeted therapy, it acts on the mTOR signaling pathway. The extent of benefit varies from person to person, depending on the type of cancer, overall health, and how the body responds to therapy. Afinitor is not a stand-alone plan. It works as part of a broader care plan led by your oncology team, with regular lab work and imaging.
As with any medication, Afinitor may cause side effects. Common ones include mouth sores, fatigue, rash, a higher risk of infection, and raised cholesterol or triglycerides. Your healthcare provider will monitor you throughout treatment and assess whether Afinitor remains a suitable option for you.
BENEFITS
For people with certain advanced cancers, the main goal of Afinitor is to slow cancer progression. Keeping tumor growth under control is a central part of a treatment plan led by your oncology team.
Afinitor is a targeted therapy. It acts on one specific route, the mTOR signaling pathway, so your team can choose it when mTOR-targeted treatment suits your cancer and your overall care plan.
Afinitor is a daily tablet, so it does not require injections or infusions. You take it at the same time each day, with or without food, which makes it easier to build into your routine.
In selected cancers, Afinitor may help delay progression. Because treatment is generally long term, lasting as long as the cancer stays controlled and side effects are manageable, regular visits, imaging, and lab work help your team see how well it is working for you.
Your healthcare provider will discuss the potential benefits and risks before treatment and provide ongoing support, including regular blood and lab monitoring, to help ensure safe use.
SUPPORTING YOUR RESULTS
Daily habits are an important part of a comprehensive treatment plan alongside Afinitor. Taking your medicine exactly as prescribed, protecting yourself from common side effects, and keeping up with monitoring all play a role in supporting your results.
These habits can help you stay on therapy and manage side effects such as mouth sores, infection risk, and skin sensitivity. Your oncology team can tailor these steps to your situation.
Areas that may support treatment:
Common questions
Afinitor is used in oncology to treat certain cancers, including certain types of advanced or metastatic cancer. It is a prescription everolimus tablet in the mTOR inhibitor class. It works by slowing cancer cell growth and reducing tumor proliferation. Zortress also contains everolimus, but it is used to prevent organ rejection after liver transplantation. Your oncology team decides whether Afinitor fits your diagnosis and treatment goals, so talk with your healthcare provider about your situation.
Afinitor may be considered for people with certain types of advanced or metastatic cancer, but your oncology team makes that decision. Your provider may consider it if you need targeted therapy to control tumor growth, need systemic therapy for cancer progression, or are treated under a specialist oncology protocol. Suitability depends on your cancer, overall health, and treatment goals. Ask your healthcare provider whether an mTOR-targeted treatment such as Afinitor is right for you.
Afinitor may help slow cancer growth and delay progression in selected cancers, but results vary from person to person. It blocks the mTOR pathway that cells use to grow and divide, and it reduces tumor angiogenesis and growth signaling. Your oncology team tracks your response with imaging, lab work, and regular monitoring of blood counts, liver function, kidney function, and lipid levels. Ask your healthcare provider what to expect in your situation.
The common side effects of Afinitor are mouth sores, fatigue, rash, a higher risk of infection, and raised cholesterol or triglycerides. Good oral hygiene, hand hygiene, and sun protection with sunscreen and protective clothing may help reduce some of these problems. Your healthcare provider will monitor you throughout treatment. Tell your care team about any side effects or unusual symptoms so they can decide whether Afinitor remains a suitable option for you.
The typical Afinitor dose is 10 mg once daily, taken at the same time each day, with or without food. Your healthcare provider may adjust the dose based on your indication, how well you tolerate it, and your response. Avoid grapefruit products unless your provider approves them. Store tablets at room temperature, away from moisture and heat. Never change your dose or skip doses without talking to your healthcare provider.
Afinitor is generally taken long term, for as long as the cancer stays controlled and side effects are manageable. Treatment may continue for months or years, depending on disease progression and response to therapy. Regular monitoring and appointments help your team decide how long you should continue. Do not stop taking Afinitor on your own. Talk with your healthcare provider before making any change to your treatment.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
